GlassScriptPhysician profile
Mackenzi E Ramus
NPI 1881083053
$2,469.41
in general payments reported to CMS, 2019-2025
17 companies · $962 in 2025
The $962 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $679 · 2024: $626 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.24 |
| Education | $223.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $754.04 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $341.28 | 2023-2025 | Inspire |
| Optinose US, INC. | $272.78 | 2022-2025 | |
| Genzyme Corporation | $239.16 | 2022-2025 | |
| Glaxosmithkline, LLC. | $160.85 | 2022-2025 | Nucala |
| Phathom Pharmaceuticals, INC. | $118.56 | 2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $107.94 | 2024-2025 | |
| Abbvie INC. | $91.48 | 2023 | |
| Kaleo, INC. | $89.27 | 2022-2024 | Auvi-Q |
| Novartis Pharmaceuticals Corporation | $63.49 | 2024-2025 | |
| Stryker Corporation | $59.02 | 2022-2023 | Scopis Ent |
| Merck Sharp & Dohme LLC | $41.47 | 2025 | Keytruda |
| Hologic Sales and Service, LLC | $39.93 | 2023 | Coolseal Generator |
| Intersect Ent, INC. | $25.65 | 2022 | |
| Ascendis Pharma Endocrinology INC | $23.14 | 2025 | Yorvipath |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $21.26 | 2025 | Nuzyra |
| Ars Pharmaceuticals Operations, INC. | $20.09 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzi Ramus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.